Cite
APA Citation
Halmos, B., Pennell, N. A., Fu, P., Saad, S., Gadgeel, S., Otterson, G. A., Mekhail, T., Snell, M., Kuebler, J. P., Sharma, N., & Dowlati, A. (2015). randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib‐Responsive Non‐Small Cell Lung Cancer. Oncologist, 20, 1298–1303. http://access.bl.uk/ark:/81055/vdc_100054383523.0x00002f